Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative Colitis
David T. Rubin(University of California System), Laurent Peyrin‐Biroulet(Délégation Centre-Est), Olga Kubassova(University of Leeds), Fátima Carneiro(University of Siena), Luc Biedermann(University of Zurich), Wei Xiong(Army Medical University), Matthias S. Matter(University of Basel), Jan Hendrik Niess(University of Basel), Jamshid Dehmeshki(Genomics England), Fernando Magro(Universidade do Porto), Chen Mayer(Sheba Medical Center), Brian Bressler(University of British Columbia), Marcelo Freire(J. Craig Venter Institute), Iris Barshack(Tel Aviv University), Ariel Greenberg(Tel Aviv Sourasky Medical Center), Shashi Adsul(Takeda (United States)), Nitsan Maharshak(Yale University), Uri Kopylov(Sheba Medical Center), Viktor H. Koelzer(University of Basel), Christopher R. Weber(University of Chicago), Simon P. Hart(University of Hull)
Cited by 19
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k